Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18669874 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide;   Drug: Zometa

Indicates status has not been verified in more than two years